X @The Wall Street Journal
The Wall Street Journal·2026-02-16 05:00
While nearly 18% of U.S. adults have taken a GLP-1 drug for weight loss or to treat a chronic condition, about half of people will stop taking it within a year. Often, they don’t understand what is likely to come next. 🔗: https://t.co/V2GlvOVg8F https://t.co/wcHP69priw ...